Vimarsana
Biggest News Aggregation in the World

Lymph Node Metastasis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymph Node Metastasis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymph Node Metastasis Today - Breaking & Trending Today

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases - Vimarsana News

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases

1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity

For Pet's Sake: Lymphoma is one of the more common types of cancer - Vimarsana News

For Pet's Sake: Lymphoma is one of the more common types of cancer

Lymphoma is one of the more common types of cancer that I see in my middle age to older canine patients. As with humans, lymphoma is a cancer of the lymphatic s

Nanoparticle Targets Lymph Nodes for Improved MRI Detection - Vimarsana News

Nanoparticle Targets Lymph Nodes for Improved MRI Detection

The Chung Lab at USC has developed a nanoparticle that attaches to immune cells, allowing it to target lymph nodes—a vital indicator of cancer metastasis—and enhance MRI detection, potentially revolutionizing cancer screenings by improving early detection of metastasis without invasive biopsies.

Dutch consortium investigates biomarker to identify early-stage melanoma at high-risk of recurrence - Vimarsana News

Dutch consortium investigates biomarker to identify early-stage melanoma at high-risk of recurrence

Today, SkylineDx announced a research collaboration with an academic hospital and a Dutch cancer registry to investigate patients with early-stage melanoma (skin cancer) at high risk of disease-related fatality. Approximately 90% of all melanoma patients are diagnosed with an early-stage melanoma (American Joint Classification on Cancer [AJCC] stage I/II), without any lymph node metastasis or distant metastasis at time of diagnosis. However, 41% of melanoma-related deaths, are these early-stage patients that are anticipated to have a good prognosis at their diagnosis. As current predictors are...

Source: yahoo.com